- Forums
- ASX - By Stock
- MSB
- Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L, page-961
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.087B |
Open | High | Low | Value | Volume |
98.0¢ | 98.5¢ | 95.0¢ | $2.395M | 2.483M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 19815 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
91.5¢ | 13260 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 57659 | 1.015 |
2 | 16901 | 1.010 |
7 | 43187 | 0.995 |
12 | 88418 | 0.990 |
4 | 5465 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
0.915 | 13260 | 4 |
0.920 | 6792 | 3 |
0.940 | 32066 | 3 |
0.945 | 24327 | 4 |
0.950 | 44854 | 10 |
Last trade - 15.59pm 13/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online